| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.10 | $2.27 | $2.06 | $1.90 | $1.15 | $1.47 | $1.50 |
| EPS (Diluted) | $2.10 | $2.27 | $2.06 | $1.90 | $1.15 | $1.47 | $1.50 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $2.7B | $2.6B | $2.5B | $2.4B | $2.2B | $2.0B | $1.5B |
| Current Assets | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | $0.3B | $0.3B |
| Total Liabilities | $2.3B | $2.2B | $2.2B | $2.1B | $1.9B | $1.7B | $1.3B |
| Current Liabilities | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.1B | $0.1B | $0.1B | $-0.1B | $-0.1B | $0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | — | — | — |
| Financing Cash Flow | $0.1B | $0.0B | $-0.3B | $0.1B | $0.1B | $-0.0B | $0.1B |